As platform technology, we stack efficiencies at each stage from plasmid design to purification.
Arktos’ platform enables rapid production of customer protein, irrespective of target protein attributes.
Scalability is realized by a modular platform design, accommodating both R&D to cGMP.
Our spCas9 products are produced under stringent quality controls to ensure high purity, activity, and consistency.
R&D and cGMP grade CRISPR-Cas proteins
Custom CRISPR-Cas systems can be produced upon request.
Make proteins for research, diagnostics, and therapeutic use.
Our capabilities extend from small-batch to large manufacturing scale production, enabling continuity.
Better lead times from Arktos allows for our customers to see results faster.